Taxifolin, Extracted from Waste Larix olgensis Roots, Attenuates CCl4-Induced Liver Fibrosis by Regulating the PI3K/AKT/mTOR and TGF-β1/Smads Signaling Pathways-Reference-Cited by-同舟云学术

Taxifolin, Extracted from Waste Larix olgensis Roots, Attenuates CCl4-Induced Liver Fibrosis by Regulating the PI3K/AKT/mTOR and TGF-β1/Smads Signaling Pathways

Published:2021-02 Issue: Volume:Volume 15 Page:871-887
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Liu Xinglong,Liu Wencong,Ding Chuanbo,Zhao Yingchun,Chen Xueyan,Ling Dong,Zheng Yinan,Cheng Zhiqiang

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference51 articles.

1. Liver fibrosis

2. Mesenchymal stem cell therapy for liver fibrosis

3. Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets

4. Origin of myofibroblasts in the fibrotic liver in mice

5. Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of flavonoids in hepatic fibrosis: A comprehensive review;Phytomedicine;2024-10

2. Mechanism of Action of Dihydroquercetin in the Prevention and Therapy of Experimental Liver Injury;Molecules;2024-07-27

3. The role of PI3k/AKT signaling pathway in attenuating liver fibrosis: a comprehensive review;Frontiers in Medicine;2024-03-25

4. Determination of In Vitro and In Vivo Effects of Taxifolin and Epirubicin on Epithelial–Mesenchymal Transition in Mouse Breast Cancer Cells;Technology in Cancer Research & Treatment;2024-01

5. Research Progress in Traditional Chinese Medicine to Improve Nonalcoholic Fatty Liver Disease by Regulating Leptin-Related Pathways;Traditional Chinese Medicine;2024